(Q39712940)

14 September 2017

title

Dendritic cells expressing soluble CTLA4Ig prolong antigen-specific skin graft survival (English)

1 reference

14 September 2017

1 reference

Francesco L Ierino

1

1 reference

14 September 2017

William Mulley

2

1 reference

14 September 2017

Natalie Dodge

3

1 reference

14 September 2017

Yu Qin Li

4

1 reference

14 September 2017

Effie Mouhtouris

5

1 reference

14 September 2017

Dale Christiansen

6

1 reference

14 September 2017

Mauro S Sandrin

7

1 reference

14 September 2017

publication date

20 April 2010

1 reference

Immunology & Cell Biology

14 September 2017

published in

1 reference

14 September 2017

volume

88

1 reference

14 September 2017

issue

8

1 reference

14 September 2017

page(s)

846-850

1 reference

Dendritic cells and the control of immunity

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

The dendritic cell system and its role in immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

Dendritic cells, T cell tolerance and therapy of adverse immune reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

Potential of tolerogenic dendritic cells for transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

A dendritic cell line genetically modified to express CTLA4-IG as a means to prolong islet allograft survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

Effective induction of immune tolerance by portal venous infusion with IL-10 gene-modified immature dendritic cells leading to prolongation of allograft survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

CTLA-4 is a second receptor for the B cell activation antigen B7

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

CTLA-4-Ig regulates tryptophan catabolism in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

IDO expression by dendritic cells: tolerance and tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

Additive efficacy of CTLA4Ig and OX40Ig secreted by genetically modified grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

Transplantation of islets transduced with CTLA4-Ig and TGFbeta using adenovirus and lentivirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

Locally expressed CTLA4-Ig in a pancreatic beta-cell line suppresses accelerated graft rejection response induced by donor-specific transfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

Secretion of CTLA4Ig by an SV40 T antigen-transformed islet cell line inhibits graft rejection against the neoantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

Feasibility of CTLA4Ig gene delivery and expression in vivo using retrovirally transduced myeloid dendritic cells that induce alloantigen-specific T cell anergy in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

Treatment of an immortalized APC cell line with both cytokines and LPS ensures effective T-cell activation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

Indoleamine 2,3 dioxygenase and regulation of T cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

Inhibition of T cell proliferation by macrophage tryptophan catabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

Dendritic cells: tools and targets for transplant tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

Lentiviral expression of CTLA4Ig inhibits primed xenogeneic lymphocyte proliferation and cytokine responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

Differential cytokine expression and regulation of human anti-pig xenogeneic responses by modified porcine dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

PROLONGED XENOGRAFT SURVIVAL OF ISLETS INFECTED WITH SMALL DOSES OF ADENOVIRUS EXPRESSING CTLA4Ig1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

7 January 2021

Expression of CTLA4-Ig by biolistically transfected mouse islets promotes islet allograft survival

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

7 January 2021

Protective effect of CTLA4Ig secreted by transgenic fetal pancreas allografts

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

7 January 2021

Genetic engineering of dendritic cells to express immunosuppressive molecules (viral IL-10, TGF-beta, and CTLA4Ig).

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

7 January 2021

Blockade of CD40 pathway enhances the induction of immune tolerance by immature dendritic cells genetically modified to express cytotoxic T lymphocyte antigen 4 immunoglobulin

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

7 January 2021

Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FICB.2010.58

7 January 2021

Identifiers

DOI

10.1038/ICB.2010.58

1 reference

14 September 2017

1 reference